Liquidia (LQDA) Income towards Parent Company (2020 - 2026)

Liquidia (LQDA) recorded quarterly Income towards Parent Company of $52.9 million in Q1 2026, up 263.33% quarter-over-quarter from $14.6 million in Q4 2025, and up 237.83% on a YoY basis from $15.7 million in Q1 2025.

Liquidia (LQDA) Income towards Parent Company (2020 - 2026) Analysis & Trends

Liquidia's Income towards Parent Company history runs 7 years deep, the most recent figure standing at $52.9 million for Q1 2026.

  • In Q1 2026, Income towards Parent Company rose 237.83% year-over-year to $52.9 million; the TTM figure through Mar 2026 stood at $22.3 million (up 116.35% YoY), while the FY2025 annual figure was -$68.9 million, up 46.28% from the prior year.
  • Income towards Parent Company was $52.9 million for Q1 2026 at Liquidia, up from $14.6 million in the prior quarter.
  • In the past five years, Income towards Parent Company ranged from a high of $52.9 million in Q1 2026 to a low of -$41.6 million in Q2 2025.
  • Historically, Income towards Parent Company has averaged -$15.3 million across 5 years, with a median of -$15.8 million in 2023.
  • The sharpest annual moves came in 2023 and 2026: Income towards Parent Company slumped 320.17% in 2023, then jumped 237.83% in 2026.
  • A 5-year view of Income towards Parent Company shows it stood at -$6.5 million in 2022, then plunged by 320.17% to -$27.4 million in 2023, then tumbled by 40.29% to -$38.5 million in 2024, then jumped by 137.8% to $14.6 million in 2025, then soared by 263.33% to $52.9 million in 2026.
  • The last three Income towards Parent Company figures came in at $52.9 million (Q1 2026), $14.6 million (Q4 2025), and -$3.5 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 38.77 Bn 35.04 Bn 1.97 Bn
2 Zoetis 34.11 Bn 32.16 Bn 1.62 Bn
3 United Therapeutics 23.68 Bn 21.53 Bn 648.10 Mn
4 Aurora Cannabis 16.48 Bn 16.40 Bn 33.43 Mn
5 Neurocrine Biosciences 16.19 Bn 14.88 Bn 800.70 Mn
6 Elanco Animal Health 11.44 Bn 11.01 Bn 785.00 Mn
7 Alkermes 7.28 Bn 6.77 Bn -116.06 Mn
8 Lantheus Holdings 6.48 Bn 5.98 Bn 230.92 Mn
9 Hims & Hers Health 6.35 Bn 5.60 Bn 396.79 Mn
10 Liquidia 5.74 Bn 5.52 Bn 121.79 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 52.88 Mn
Dec 31, 2025 14.56 Mn
Sep 30, 2025 -3.53 Mn
Jun 30, 2025 -41.58 Mn
Mar 31, 2025 -38.37 Mn
Dec 31, 2024 -38.51 Mn
Sep 30, 2024 -31.03 Mn
Jun 30, 2024 -28.67 Mn
Mar 31, 2024 -30.08 Mn
Dec 31, 2023 -27.45 Mn
Sep 30, 2023 -15.79 Mn
Jun 30, 2023 -23.52 Mn
Mar 31, 2023 -9.43 Mn
Dec 31, 2022 -6.53 Mn
Sep 30, 2022 -9.09 Mn
Jun 30, 2022 -9.45 Mn
Mar 31, 2022 -14.95 Mn
Dec 31, 2021 -11.56 Mn
Sep 30, 2021 -7.28 Mn
Jun 30, 2021 -6.55 Mn